• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COCHLEAR BONE ANCHORED SOLUTIONS AB BIA400 IMPLANT 4MM W ABUTMENT 12MM; COCHLEAR BAHA CONNECT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COCHLEAR BONE ANCHORED SOLUTIONS AB BIA400 IMPLANT 4MM W ABUTMENT 12MM; COCHLEAR BAHA CONNECT SYSTEM Back to Search Results
Model Number 93332
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Impaired Healing (2378); Skin Infection (4544)
Date of Event 12/04/2022
Type of Reportable Event Serious Injury
Event or Problem Description
Per the clinic, the patient experienced skin overgrowth.The device (both implant and abutment) was explanted on (b)(6) 2022.The patient was re-implanted with a new device in the same procedure.
 
Additional Manufacturer Narrative
This report is submitted on january 5, 2023.
 
Additional Manufacturer Narrative
Per the clinic, it was reported that the patient experienced an infection at the implant site (date not reported).Additional information has been requested but it has not been made available as of the date of this report.This report is submitted on march 01, 2023.
 
Additional Manufacturer Narrative
Correction: the previous mdr submitted on march 01, 2023, was filed inadvertently.No infection has occurred.The reported adverse event is associated with a returned device; however, the provided clinical information was reviewed by the manufacturer and no specific device analysis is deemed necessary at this time.Previous product examinations have not showed any relationship between a product geometrical deviation and the reported clinical complication.Additionally, there are no indications that a product failure has contributed to the reported issue.Adverse skin reactions around the baha abutment, ranging from slight redness to infected tissue, are common complications with baha implants, and can occur at any time following implantation.The report frequency for these complications is being monitored under cbas complaint and medical device reporting data monitoring plan and the status is updated on a monthly basis.This event is added to this monitoring.This report is submitted on april 18, 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIA400 IMPLANT 4MM W ABUTMENT 12MM
Common Device Name
COCHLEAR BAHA CONNECT SYSTEM
Manufacturer (Section D)
COCHLEAR BONE ANCHORED SOLUTIONS AB
konstruktionsvägen 14
po box 82
mölnlycke, 435 3 3
SW  435 33
Manufacturer (Section G)
COCHLEAR BONE ANCHORED SOLUTIONS AB
konstruktionsvägen 14
mölnlycke, 435 3 3
SW   435 33
Manufacturer Contact
nabila zahari
unit ug-1, vertical podium
no. 8 jalan kerinchi,
kuala lumpur, wilayah persekutuan 59200
MY   59200
MDR Report Key16099820
Report Number6000034-2023-00074
Device Sequence Number12319080
Product Code MAH
UDI-Device Identifier09321502022385
UDI-Public(01)09321502022385(10)COH1129957(11)07312017(17)06202022
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K121317
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date06/20/2022
Device Model Number93332
Device Catalogue Number93332
Device Lot NumberCOH1129957
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 12/14/2022
Supplement Date Received by Manufacturer02/03/2023
03/30/2023
Initial Report FDA Received Date01/04/2023
Supplement Report FDA Received Date03/01/2023
04/18/2023
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/31/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age76 YR
Patient SexMale
-
-